Package 63323-574-93

{"route": ["SUBCUTANEOUS"], "spl_id": "d1c9afa7-c4ac-4739-85f1-2ae82440210c", "openfda": {"unii": ["325O8467XK"], "rxcui": ["1148141"], "spl_set_id": ["52c12c15-c00b-4efc-952d-1425c907706a"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (63323-574-86)  / 3 mL in 1 SYRINGE (63323-574-01)", "package_ndc": "63323-574-86", "marketing_start_date": "20201115"}, {"sample": false, "description": "3 CARTON in 1 BOX (63323-574-93)  / 1 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE", "package_ndc": "63323-574-93", "marketing_start_date": "20201115"}], "brand_name": "Icatibant", "product_id": "63323-574_d1c9afa7-c4ac-4739-85f1-2ae82440210c", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Bradykinin B2 Receptor Antagonist [EPC]", "Bradykinin B2 Receptor Antagonists [MoA]"], "product_ndc": "63323-574", "generic_name": "Icatibant", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Icatibant", "active_ingredients": [{"name": "ICATIBANT ACETATE", "strength": "10 mg/mL"}], "application_number": "ANDA208317", "marketing_category": "ANDA", "marketing_start_date": "20201115", "listing_expiration_date": "20261231"}